MedTrace Logo

Drug and Dose Adjustment in Preventing Postoperative Nausea and Vomiting

NCT04719741 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2022-03-29

No results posted yet for this study

Summary

The aim is to evaluate the effectiveness of different regimens of prophylactic Ondansetron, Dexamethasone, or both, on the incidence and severity of post-operative nausea and vomiting.

Conditions

  • Postoperative Nausea and Vomiting

Interventions

OTHER

Parallel Assignment

Prospective, Triple blinded, randomized, controlled trial

Sponsors & Collaborators

  • Jordan Hospital

    lead OTHER

Principal Investigators

  • AbdulRhman MA Ibnouf, MBBS · Anaesthesia Department, Jordan Hospital

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2024-05-20
Completion
2024-08-20
FDA Drug
Yes

Countries

  • Jordan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04719741 on ClinicalTrials.gov